Therefore, we can speculate that increased BMP6 activity in the ovaries of patients with PCOS might inhibit the expression of PTX3 through specific pathways, leading to oocyte development arrest and ovulation disorders. This evidence concerns the gene PTX3 and polycystic ovary syndrome.